Evidence Hub

Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report

Xia Zou, Kun Wang, Rui Zeng

The American journal of case reports, 2025

1 citation

Abstract

Patient: Male, 57-year-old Final Diagnosis: Light chain proximal tubulopathy Symptoms: Fatigue • nocturia • hypokalemia Clinical Procedure: — Specialty: Nephrology Objective: Rare coexistence of disease or pathology Background Light chain proximal tubulopathy (LCPT) is a rare monoclonal immunoglobulin light chain-associated kidney disease. A few clinical case reports have shown that lenalidomide is an effective treatment for LCPT. Daratumumab, an anti-CD38 monoclonal antibody, has demonstrated efficacy in multiple myeloma and light chain amyloidosis, with good hematologic and organ response. However, the role of daratumumab in non-amyloid monoclonal gammopathy of renal significance requires further validation. Case Report This report describes a case of LCPT that was unresponsive to lenalidomide but responded favorably to a daratumumab-based regimen. A middle-aged man presented with fatigue, nocturia, and hypokalemia as initial symptoms upon admission. Auxiliary examinations indicated renal dysfunction, without proteinuria. During the evaluation of secondary causes of renal dysfunction, serum immunofixation electrophoresis detected an IgA-Kappa-type M proteinemia, prompting a bone marrow aspiration for definitive diagnosis, which revealed 3% immature plasma cells. Finally, LCPT was diagnosed based on renal biopsy. After the diagnosis of the disease, early treatment with lenalidomide was not effective. However, after 5 cycles of treatment with daratumumab and dexamethasone,…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free